Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Bietti crystalline retinal dystrophy is a rare, inherited disorder whose hallmark is the presence of retinal crystaldeposits associated with later chorioretinal degeneration. This condition may rarely be complicated bythe development of cystoid macular oedema leading to rapid visual decline. Currently, treatment options forthis complication of Bietti dystrophy are limited and the visual prognosis is poor. Here, we present a case ofcystoid macular oedema associated with Bietti dystrophy that was successfully diagnosed using multimodalimaging techniques including optical coherence tomography and fluorescein angiography. These modalitiesconfirmed the diagnosis of macular oedema and excluded other possible causes of oedema such aschoroidal neovascularisation. In this patient, cystoid macular oedema was resolved with oral acetazolamidetherapy, a treatment that has not been previously reported in this context. Acetazolamide treatment resultedin oedema resolution and improvement in visual function, and can be considered a therapeutic optionfor other patients with Bietti dystrophy who develop cystoid macular oedema.
Abstract
Bietti crystalline retinal dystrophy is a rare, inherited disorder whose hallmark is the presence of retinal crystaldeposits associated with later chorioretinal degeneration. This condition may rarely be complicated bythe development of cystoid macular oedema leading to rapid visual decline. Currently, treatment options forthis complication of Bietti dystrophy are limited and the visual prognosis is poor. Here, we present a case ofcystoid macular oedema associated with Bietti dystrophy that was successfully diagnosed using multimodalimaging techniques including optical coherence tomography and fluorescein angiography. These modalitiesconfirmed the diagnosis of macular oedema and excluded other possible causes of oedema such aschoroidal neovascularisation. In this patient, cystoid macular oedema was resolved with oral acetazolamidetherapy, a treatment that has not been previously reported in this context. Acetazolamide treatment resultedin oedema resolution and improvement in visual function, and can be considered a therapeutic optionfor other patients with Bietti dystrophy who develop cystoid macular oedema.
참고문헌 (9)
- Wilson DJ, "Bietti’s crystalline dystrophy. A clinicopathologic correlative study", Arch Ophthalmol, 107, pp.213~221 (1989)
- Rossi S, "Clinical and genetic features in Italian Bietti crystalline dystrophy patients", Br J Ophthalmol, 97, pp.174~179 (2013)
- Atmaca LS, "Peripapillary choroidal neovascularization in Bietti crystalline retinopathy", Eye, 21, pp.839~842 (2007)
- Li A, "Bietti crystalline corneoretinal dystrophy is caused by mutations in the novel gene CYP4V2", Am J Hum Genet, 74, pp.817~826 (2004)
- Parravano M, "Bietti crystalline dystrophy: a morpho-functional evaluation", Doc Ophthalmol, 124, pp.73~77 (2012)
- Fishman GA, "Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa", Arch Ophthalmol, 107, pp.1445~1452 (1989)
- Wolfensberger TJ, "Inhibition of membrane-bound carbonic anhydrase enhances subretinal fluid absorption and retinal adhesiveness", Graefes Arch Clin Exp Ophthalmol, 238, pp.76~80 (2000)
- Ghajarnia M, "Acetazolamide in the treatment of X-linked retinoschisis maculopathy", Arch Ophthalmol, 125, pp.571~573 (2007)
- Iannaccone A, "Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide", Am J Ophthalmol, 147, pp.307~312 (2009)